logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Amarin (AMRN) Plunges Again on FDA Announcement

By  +Follow October 30, 2013 9:36AM
Share:
Tickers Mentioned:

Amarin Pharmaceuticals (AMRN) took another hit Wednesday during a year that’s been a rough one for the company as a whole. Amarin was off over 14 percent in trading on Wednesday after the FDA told the company on Tuesday that its triglyceride-reducing drug, Vascepa, didn’t show strong enough results to merit approval.

Vascepa Fails to Show Results

The FDA contacted Amarin after market-close on Tuesday to report that Vascepa failed to reduce triglycerides enough to be marketed to patients for reducing the risk of cardiovascular disease. Vascepa is a prescription-strength supplement that uses Omega-3 fatty acids from fish oils. The drug was approved in 2012 for use in some patients with unusually high triglyceride levels, but the FDA reversed that ruling on Tuesday, sending shares lower.

This comes just two weeks after an FDA panel voted against approval of Vascepa and called for a lengthy and expensive study on the drug’s ability to prevent cardiovascular events like heart attacks, a decision that came as a surprise for many. The decision prompted Amarin to cut staff and prompted a nearly 60 percent decline in the company’s stock.

A Tough Year for Amarin

Today’s hit is a bad one. But in a year that’s seen shares plunge over 85 percent since Halloween in 2012, it’s probably not going to register for any long-time Amarin stockholders. The company has few options other than to continue running losses while engaging in the lengthy Vascepa study without a clear sense that there’s a light at the end of the tunnel.

With the layoffs last week, Amarin’s situation appears bleak, though not entirely unmanageable. Amarin believes that it has the cash on hand to make it through the next few years without raising additional capital.

“As of September 30, 2013, Amarin had cash, cash equivalents of approximately $226 million,” the company announced last Tuesday. “Amarin anticipates approximately $3 million in restructuring expense in association with this reduction in staffing. The company currently expects its cash burn for 2014 to be less than $80 million. The company has no plans for raising additional capital at this time. Amarin intends to continue its evaluation of priorities, opportunities and savings opportunities, including clinical trial costs. The company plans to provide additional details of its future spending and operational expectations in connection with its upcoming quarterly report.”

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for AMRN
JohnCappello
18 Sep 14 02:20:28
Commented on StockTwits: An accuate assessment, Big question: Can $AMRN grab enough $1B Rx pie to avoid dilution... http://t.co/T7yIzTnnA2
iHangout
18 Sep 14 01:07:48
http://t.co/l4qmOlz0qf chartguy89: Stock Charts: AMRN 1.37 Stock Charts $AMRN Amarin Corp. PLC ADS http://t.co/3JwwLeVDHf
Stock Rocket
17 Sep 14 23:49:45
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $PHMB $FNRC $AMRN
Flight Leader Funds
17 Sep 14 20:22:29
@adamfeuerstein I'm trying to get an article published on $AMRN decision. The articles go through you, can you help publish?
Stock Forums
17 Sep 14 19:06:42
$AMRN Chart Click Here: http://t.co/3Ls64Z2z8T Also See: $OTIV $V $DRYS $AKS ~
Rosner Stocks
17 Sep 14 18:46:18
$AMRN Ask Size Click Here: http://t.co/jXq87GL3de Also See: $IBB $SINO $NWBO $WMIH ~
Investors Hangout
17 Sep 14 18:38:33
$AMRN Chart Click Here: http://t.co/bdQE1OEUSB Also See: $RSP $SUNE $CSX $SSO ~
Chasing Stars
17 Sep 14 18:34:22
$AMRN Bid Size Click Here: http://t.co/VgsK1xfl7s Also See: $LHPT $DIGX $LXRP $MU ~
Investors Hangout
17 Sep 14 18:31:00
$AMRN Exchange Click Here: http://t.co/zvJCCbtxXB Also See: $COP $F $PLKD $LVLT ~
Rosner Stocks
17 Sep 14 18:14:00
$AEM Open Click Here: http://t.co/FfbYapqCLJ Also See: $S $ANY $AMRN $HPQ ~
JohnCappello
17 Sep 14 17:25:31
thanks to #FDA rescinding SPA , cats, dogs to get optimal EPA;AA ratio years before humans w/ CVD risk $AMRN WTF? http://t.co/a20un5LQf5
Chasing Stars
17 Sep 14 16:36:25
$RSII Chart Click Here: http://t.co/meWtrYaKOK Also See: $T $SUNE $FXE $AMRN ~
Investors Hangout
17 Sep 14 13:46:33
$HHSE Day High Click Here: http://t.co/3ktw5H9mGu Also See: $AMRN $HFCO $SSO $MINE ~
Stock Rocket
17 Sep 14 12:57:50
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $PHMB $FNRC $AMRN
Zacks.com
17 Sep 14 12:17:49
Don't miss our #Biotech roundup! $OREX $GILD $CELG $MDVN $AVNR $AMRN $NPSP http://t.co/xo2vWKw5Ix
Stock Forums
17 Sep 14 11:32:22
$AZFL Prev Close Click Here: http://t.co/8Ptfd0T0sh Also See: $SGLB $WMIH $EPGL $AMRN ~
Investors Hangout
17 Sep 14 10:54:41
$AAPL Stock Forum Click Here: http://t.co/rlK0cwCHZ2 Also See: $ALL $GOOG $AMRN $PTAH ~
Stockaholics
17 Sep 14 10:48:32
$RSII gained 150% in 4 days! Get our top penny stock picks early: http://t.co/iSqL7zgTT1 $PHMB $FNRC $AMRN
JohnCappello
17 Sep 14 10:39:05
Combo patent app 14/179665 w/ this: http://t.co/JS9HLw6cTA $AMRN
Bullrunner911
17 Sep 14 10:39:02
$AMRN fda based decision on the panel...just watch the panel meeting and how 2 people railroaded entire proceedings.
JohnCappello
17 Sep 14 10:30:27
get ready, another EPA "home run" to be published in Journal of Cardiology $AMRN
Bullrunner911
17 Sep 14 10:28:31
Commented on StockTwits: $amrn but trigs of 200-500 not bad per fda actions. lol....only obese people need to red... http://t.co/HPq3aUIEZI
JohnCappello
17 Sep 14 10:25:28
more on the gene we love to hate - why bother? http://t.co/jqsxXT18cY $AMRN
JohnCappello
17 Sep 14 10:23:20
New study: TGs lowered dramatically by gene, But why anyone would want to lower TGs is beyond me http://t.co/NRNhQ7XVVE $AMRN
Bullrunner911
17 Sep 14 09:29:12
$AMRN market treating the stock like we dont have an approved drug. I first bought amrn at 3.75 before marine trial results published.
Bullrunner911
17 Sep 14 09:28:42
$AMRN what everyone misses is that the panel simply wanted to wait till outcomes trial results.
OTCADDICT
17 Sep 14 09:25:14
RT @TraderNewsDaily: http://t.co/PeRPkYu8Uk ranks #1 with over 80% in alert gains today. Related: $HALB $GRLT $ATML $ANV $AMRN $KIOR $ORE…
Langan Stocks
17 Sep 14 08:38:51
$EMC Bid Click Here: http://t.co/Dh3XTBXMpQ Also See: $AMRN $FLY.V $XLI $JNK ~
IH News Desk
17 Sep 14 08:34:14
$EBAY Ex-Div Date Click Here: http://t.co/sfbCa0kQeU Also See: $AMRN $KNDI $EA $Z ~
Ticker Report
17 Sep 14 08:27:45
Amarin Co. plc Given Reduce Rating at Jefferies Group $AMRN http://t.co/n3gp6WyV7Z
WKRB News
17 Sep 14 07:53:05
Jefferies Group Reiterates “Reduce” Rating for Amarin Co. plc $AMRN http://t.co/lPWA6tl06s
Zenhunter
17 Sep 14 07:37:52
Bought back some $AMRN for the bounce. Can't stay away from this one if it is bouncing.
Rob Wright
17 Sep 14 07:26:56
RT @matthewherper: Yes. MT @DewDiligence $AMRN finally talking like a serious drug co rather than a "virtual" biotech who encourages retai…
DigitalDeath
17 Sep 14 06:53:40
My Puts $BLUE $AMRN and Calls $EXEL $CRIS, expires this Friday. Of all, $AMRN is the drag queen.
Crazy kid
17 Sep 14 06:38:23
$AMRN Load the Boat!!!
nasdaqfan
17 Sep 14 05:54:25
$BITA Day Low Click Here: http://t.co/SdjuPMJJQx Also See: $MVTG $BRK/B $LUV $AMRN ~
US Banking News
17 Sep 14 05:24:38
Amarin Co. plc Receives Reduce Rating from Jefferies Group $AMRN http://t.co/wRB2eyweys
US Consumer News
17 Sep 14 05:19:34
Amarin Co. plc (ADR)'s reduce rating reiterated at Jefferies Group. http://t.co/Ysot0bh1cW $AMRN #AMRN
Analyst Ratings
17 Sep 14 05:19:27
Amarin Co. plc (ADR)'s reduce rating reiterated at Jefferies Group. http://t.co/Ser8tS02kg $AMRN #AMRN
SIAnalystWire
17 Sep 14 04:47:52
Completion of REDUCE-IT Best Way to Maximize Amarin $AMRN Vascepa L-T Value, Jefferies Says http://t.co/BL3IGdYKMW
Jake13
17 Sep 14 04:36:51
$AMRN Investor Opinions Click Here: http://t.co/Qd40z5vPuU Also See: $RMP.TO $FCX $APC $BBY ~
nasdaqfan
17 Sep 14 04:23:11
$AMRN Stock Forum Click Here: http://t.co/Ko4x855anA Also See: $USLV $LHPT $FANG $COP ~
Stock Forums
17 Sep 14 04:19:00
$AMRN Stock Message Board Click Here: http://t.co/EiM3tempzd Also See: $NUGT $SBUX $CEHC $QLD ~
IH News Desk
17 Sep 14 04:16:21
$AMRN Yield Click Here: http://t.co/8Txdv1Yp7Y Also See: $APC $EBAY $AKS $SLV ~
Rosner Stocks
17 Sep 14 04:14:18
$AMRN Open Click Here: http://t.co/R3iJoVDTIC Also See: $JNJ $FXE $SCTY $CVS ~
IH NASDAQ OMX
17 Sep 14 04:12:28
$AMRN Financials Click Here: http://t.co/gmNO5DO5Rx Also See: $SPXS $OXY $TNA $OTIV ~
PolgarStocks
17 Sep 14 04:10:05
$AMRN Last Price Click Here: http://t.co/Gj6NxENutp Also See: $BLUE $PLKD $DIS $JCP ~
clayton
17 Sep 14 04:07:38
$AMRN Short Sales Click Here: http://t.co/MfQMYezzUd Also See: $JOBS $KGC $MCIG $EA ~
Chasing Stars
17 Sep 14 04:03:33
$AMRN Bid Click Here: http://t.co/A1Cd47NLw5 Also See: $QCOM $CARA $DIGX $NVDA ~
Langan Stocks
17 Sep 14 04:00:16
$AMRN P/E Ratio Click Here: http://t.co/cyGbQwgahz Also See: $ERBB $XIV $GLUU $OXY ~
				
				
By  +Follow October 30, 2013 9:36AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.